- Molecular Targets of Cannabidiol in Neurological Disorders
- CBD: A promising drug for neurodegenerative disorders?
- CBD for neurodegenerative disorders: Important new clinical applications for this phytocannabinoid?
- Transdermal delivery of cannabidiol attenuates binge alcohol-induced neurodegeneration in a rodent model of an alcohol use disorder
- Memory-rescuing effects of cannabidiol in an animal model of cognitive impairment relevant to neurodegenerative disorders
- CBD normalizes caspase 3, synaptophysin, and mitochondrial fission protein DNM1L expression levels in rats with brain iron overload: implications for neuroprotection
- Cannabidiol, neuroprotection and neuropsychiatric disorders
- Short-term effects of CBD after global hypoxia-ischemia in newborn piglets
- CBD reduces neuroinflammation and promotes neuroplasticity and functional recovery after brain ischemia
- Short-term effects of cannabidiol after global hypoxia-ischemia in newborn piglets
- CBD Activates Neuronal Precursor Genes in Human Gingival Mesenchymal Stromal Cells
- CBD reduces brain damage and improves functional recovery in a neonatal rat model of arterial ischemic stroke
- Interactions between CBD and THC following acute and repeated dosing
- CBD attenuates OGD/R-induced damage by enhancing mitochondrial bioenergetics & modulating glucose metabolism